Assistant Attorney General for Antitrust, Makan Delrahim, responded in a letter dated May 18, to Rutgers University Professor Michael Carrier and former Federal Trade Commission Chairman Timothy Muris who, with 75 other academics and former US antitrust enforcers, wrote him on May 17, critiquing his recent speeches on patents and patent holdup.
In his reply, Mr. Delrahim affirmed the Antitrust Division’s welcome of lively discussion and research regarding its policies; cited and included in his response a letter signed by 13 prominent scholars in antitrust law and economics, former enforcers, and judges in support of those policies; and reaffirmed the Department of Justice’s view that the policies of the United States “reflect [their] observations and understanding of, among other things, actual standard setting activity, actions of participants in SSOs (including both patent holders and implementers), the current state of theoretical and empirical research into these matters, and, of course, the status of patent rights under the US Constitution.”
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan